SMAP200700061A - Trattamento delle malattie epatiche in cui il ferro svolge un ruolo nella patogenesi - Google Patents
Trattamento delle malattie epatiche in cui il ferro svolge un ruolo nella patogenesiInfo
- Publication number
- SMAP200700061A SMAP200700061A SM200700061T SM200700061T SMAP200700061A SM AP200700061 A SMAP200700061 A SM AP200700061A SM 200700061 T SM200700061 T SM 200700061T SM 200700061 T SM200700061 T SM 200700061T SM AP200700061 A SMAP200700061 A SM AP200700061A
- Authority
- SM
- San Marino
- Prior art keywords
- pathogenesis
- role
- treatment
- liver diseases
- iron plays
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68584805P | 2005-05-31 | 2005-05-31 | |
US69280805P | 2005-06-22 | 2005-06-22 | |
US74678606P | 2006-05-09 | 2006-05-09 | |
PCT/US2006/020677 WO2006130532A2 (en) | 2005-05-31 | 2006-05-30 | Treatment of liver diseases in which iron plays a role in pathogenesis |
Publications (1)
Publication Number | Publication Date |
---|---|
SMAP200700061A true SMAP200700061A (it) | 2007-12-28 |
Family
ID=37106984
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SM200700061T SMAP200700061A (it) | 2005-05-31 | 2006-05-30 | Trattamento delle malattie epatiche in cui il ferro svolge un ruolo nella patogenesi |
Country Status (16)
Country | Link |
---|---|
US (3) | US20080199428A1 (it) |
EP (1) | EP1893198A2 (it) |
JP (2) | JP2008542380A (it) |
KR (2) | KR101174966B1 (it) |
AU (1) | AU2006252718B2 (it) |
BR (1) | BRPI0610873A2 (it) |
CA (1) | CA2608709A1 (it) |
CR (1) | CR9454A (it) |
EA (1) | EA014772B1 (it) |
IL (1) | IL187000A0 (it) |
MA (1) | MA29542B1 (it) |
MX (1) | MX2007015085A (it) |
NO (1) | NO20076595L (it) |
SM (1) | SMAP200700061A (it) |
TN (1) | TNSN07447A1 (it) |
WO (1) | WO2006130532A2 (it) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY164523A (en) | 2000-05-23 | 2017-12-29 | Univ Degli Studi Cagliari | Methods and compositions for treating hepatitis c virus |
CN1315862C (zh) | 2000-05-26 | 2007-05-16 | 艾登尼科斯(开曼)有限公司 | 处理黄病毒和瘟病毒的方法和组合物 |
EP1576138B1 (en) | 2002-11-15 | 2017-02-01 | Idenix Pharmaceuticals LLC. | 2'-methyl nucleosides in combination with interferon and flaviviridae mutation |
CA2617958A1 (en) * | 2005-08-15 | 2007-02-22 | F. Hoffmann-La Roche Ag | Peg-ifn alpha and ribavirin for hbv treatment |
RU2468015C2 (ru) * | 2006-11-29 | 2012-11-27 | Новартис Аг | Полиморфные формы деферасирокса (icl670a) |
EP1927591A1 (en) * | 2006-11-29 | 2008-06-04 | Novartis AG | Polymorphic Forms of Deferasirox (ICL670) |
AU2012223528A1 (en) * | 2011-03-02 | 2013-10-24 | Joseph M. Fayad | Compositions, methods of treatment and diagnostics for treatment of hepatic steatosis alone or in combination with a Hepatitis C virus infection |
US8466159B2 (en) | 2011-10-21 | 2013-06-18 | Abbvie Inc. | Methods for treating HCV |
US8492386B2 (en) | 2011-10-21 | 2013-07-23 | Abbvie Inc. | Methods for treating HCV |
UY34401A (es) | 2011-10-21 | 2013-05-31 | Abbvie Inc | Métodos para el tratamiento de hcv |
DE202012012956U1 (de) | 2011-10-21 | 2014-10-16 | Abbvie Inc. | Kombination aus mindestens zwei direkt wirkenden antiviralen Wirkstoffen für die Verwendung zur Behandlung von HCV, umfassend Ribavirin aber nicht Interferon |
EP2770990A4 (en) * | 2011-10-28 | 2015-03-11 | Lumena Pharmaceuticals Inc | Gallic acid refluxing agent for the treatment of hypertension and chronic liver disease |
MA39748A (fr) * | 2014-03-21 | 2021-04-21 | Tobira Therapeutics Inc | Cenicriviroc pour le traitement de la fibrose |
WO2017189978A1 (en) | 2016-04-28 | 2017-11-02 | Emory University | Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY129541A (en) * | 1996-06-25 | 2007-04-30 | Novartis Ag | Substituded 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators |
JP4125011B2 (ja) * | 2002-01-22 | 2008-07-23 | 株式会社 伊藤園 | 過剰鉄起因肝障害予防・治療剤及び過剰鉄起因肝障害予防・治療飲食物 |
-
2006
- 2006-05-30 MX MX2007015085A patent/MX2007015085A/es not_active Application Discontinuation
- 2006-05-30 KR KR1020107000444A patent/KR101174966B1/ko not_active IP Right Cessation
- 2006-05-30 JP JP2008514737A patent/JP2008542380A/ja not_active Withdrawn
- 2006-05-30 WO PCT/US2006/020677 patent/WO2006130532A2/en active Application Filing
- 2006-05-30 KR KR1020077027922A patent/KR20080003933A/ko not_active Application Discontinuation
- 2006-05-30 EA EA200702384A patent/EA014772B1/ru not_active IP Right Cessation
- 2006-05-30 AU AU2006252718A patent/AU2006252718B2/en not_active Ceased
- 2006-05-30 SM SM200700061T patent/SMAP200700061A/it unknown
- 2006-05-30 CA CA002608709A patent/CA2608709A1/en not_active Abandoned
- 2006-05-30 US US11/913,678 patent/US20080199428A1/en not_active Abandoned
- 2006-05-30 BR BRPI0610873-3A patent/BRPI0610873A2/pt not_active IP Right Cessation
- 2006-05-30 EP EP06771445A patent/EP1893198A2/en not_active Withdrawn
-
2007
- 2007-10-19 CR CR9454A patent/CR9454A/es unknown
- 2007-10-29 IL IL187000A patent/IL187000A0/en unknown
- 2007-11-29 TN TNP2007000447A patent/TNSN07447A1/en unknown
- 2007-12-10 MA MA30467A patent/MA29542B1/fr unknown
- 2007-12-20 NO NO20076595A patent/NO20076595L/no not_active Application Discontinuation
-
2009
- 2009-12-18 US US12/641,690 patent/US20100098662A1/en not_active Abandoned
-
2012
- 2012-12-20 US US13/721,196 patent/US20130109730A1/en not_active Abandoned
- 2012-12-20 JP JP2012277849A patent/JP5869469B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
BRPI0610873A2 (pt) | 2010-08-03 |
AU2006252718B2 (en) | 2010-04-15 |
KR20080003933A (ko) | 2008-01-08 |
KR101174966B1 (ko) | 2012-08-17 |
US20130109730A1 (en) | 2013-05-02 |
EA200702384A1 (ru) | 2008-06-30 |
WO2006130532A3 (en) | 2007-11-22 |
JP2008542380A (ja) | 2008-11-27 |
JP5869469B2 (ja) | 2016-02-24 |
EA014772B1 (ru) | 2011-02-28 |
IL187000A0 (en) | 2008-02-09 |
TNSN07447A1 (en) | 2009-03-17 |
CA2608709A1 (en) | 2006-12-07 |
US20080199428A1 (en) | 2008-08-21 |
AU2006252718A1 (en) | 2006-12-07 |
US20100098662A1 (en) | 2010-04-22 |
CR9454A (es) | 2008-04-16 |
JP2013082726A (ja) | 2013-05-09 |
NO20076595L (no) | 2007-12-20 |
KR20100018057A (ko) | 2010-02-16 |
EP1893198A2 (en) | 2008-03-05 |
WO2006130532A2 (en) | 2006-12-07 |
MA29542B1 (fr) | 2008-06-02 |
MX2007015085A (es) | 2008-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SMAP200700061A (it) | Trattamento delle malattie epatiche in cui il ferro svolge un ruolo nella patogenesi | |
CY2014030I1 (el) | Θεραπευτικες συνθεσεις που περιλαμβανουν ingenol-3-angelate | |
EP1948298A4 (en) | BIO-INTERVENING THERAPEUTIC TREATMENT FOR HEART DISEASE DISEASES | |
EP1962961A4 (en) | HALF-BODY: THERAPEUTIC AGENTS ACTIVATED BY DIMÉRIZATION | |
DE602006016150D1 (de) | Vorbeugung von krankheiten bei kaiserschnitt-babies | |
ZA200709004B (en) | Spiroheterocyclic compounds and their uses as therapeutic agents | |
BRPI0809272A2 (pt) | Compostos de biaril e biheteroaril no tratamento de distúrbios do ferro | |
DK2144912T3 (da) | 18 f-mærkede folater | |
ITPN20050014A1 (it) | "piedino livellatore perfezionato" | |
ITRM20050179A1 (it) | Composizione impiegabile per il trattamento delle patologie paradontali. | |
EP1885384A4 (en) | TREATMENT OF LIVER DISEASES | |
SI1890705T1 (sl) | Uporaba 24-nor-UDCA za zdravljenje holestatskih bolezni jeter | |
IL211904A (en) | Kit and preparations containing methotrexate and anti-cd4 antibody for the treatment of rheumatic disease | |
HU0500145D0 (en) | Composition for the treatment of oral diseases | |
ITTO20060560A1 (it) | Composti intermedi per la preparazione di antagonisti dell¿angiotensina ii | |
ITFI20050076A1 (it) | Forma per calzature e procedimento per la manipolazione delle forme per calzature | |
FR2888750B1 (fr) | Composition pour prevenir et traiter les maladies cardiovasculaires | |
ZA200708895B (en) | Treatment of liver diseases in which iron plays a role in pathogenesis | |
AT501353A3 (de) | Sportschuh | |
FR2877961B1 (fr) | Kiosque de vente | |
IT1391251B1 (it) | Composizione per il trattamento delle patologie articolari | |
BRPI0720697A2 (pt) | Produtos para o tratamento de clorose de ferro | |
ITMI20051270A1 (it) | Laccio di sicurezza | |
FI20050667A0 (fi) | Tee Se Itse-Kaappi-Ruumisarkku | |
ITRC20060011A1 (it) | "scarpe intercambiabili" |